Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
UK’s CMA Issues £35m In Fines Over Prochlorperazine
Advanz And Alliance Plan To Appeal Against Decision By Competition Watchdog
Feb 04 2022
•
By
Dave Wallace
The CMA has issued over £35m in fines over prochlorperazine • Source: Alamy
More from Legal & IP
More from Generics Bulletin